| Symbol | NAII |
|---|---|
| Name | NATURAL ALTERNATIVES INTERNATIONAL INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals & Botanical Products |
| Address | 1535 FARADAY AVENUE, CARLSBAD, CA 92008-7319 |
| Telephone | 7607367700 |
| Fax | — |
| — | |
| Website | https://www.nai-online.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000787253 |
| Description | Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing, and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment primarily includes royalty income from its license and supply agreements associated with the sale. Additional info from NASDAQ: |
New Form S-8 - NATURAL ALTERNATIVES INTERNATIONAL INC <b>Filed:</b> 2026-05-21 <b>AccNo:</b> 0001437749-26-018078 <b>Size:</b> 212 KB
Read moreNatural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
Read moreNew Form NT 10-Q - NATURAL ALTERNATIVES INTERNATIONAL INC <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001437749-26-017638 <b>Size:</b> 27 KB
Read more(99% Neutral) NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Announces Executive Departure
Read moreCarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT01439659 | Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer | Phase2 | Ovarian Cancer | Active_Not_Recruiting | 2003-02-18 | 2026-03-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Daily Supplements | Other | Phase PHASE2 | Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT01439659 |
| Nutritional Counseling | Other | Phase PHASE2 | Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT01439659 |
| Daily Supplements | Other | Phase PHASE2 | Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT01439659 |
| Nutritional Counseling | Other | Phase PHASE2 | Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT01439659 |
| Daily Supplements | Other | Phase PHASE2 | Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT01439659 |
| Nutritional Counseling | Other | Phase PHASE2 | Ovarian Cancer | ACTIVE_NOT_RECRUITING | NCT01439659 |